HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Fejér, G. Articles by Medveczky, P. G. Search for Related Content PubMed PubMed Citation Articles by Fejér, G. Articles by Medveczky, P. G. Agricola Articles by Fejér, G. Articles by Medveczky, P. G.

The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication

György Fejér^1,

¹ Department of Medical Microbiology and Immunology, College of Medicine, University of South Florida and the H. Lee Moffitt Cancer Center, MDC Box 10, 12901 Bruce B. Downs Blvd, Tampa, FL 33612-4799, USA
² Division of Epidemiology, Department of Microbiology, Columbia University School of Public Health, New York, NY 10032, USA

Correspondence
Peter Medveczky
pmedvecz{at}hscprime.hsc.usf.edu

The genome of Kaposi's sarcoma-associated herpesvirus (KSHV) persists in latently infected cells as a circular episome. The latency-associated nuclear antigen (LANA) has been shown to tether viral DNA fragments to chromosomes and is proposed to maintain the KSHV genome. In order to identify the in vivo-binding sites for LANA on the whole KSHV genome and to analyse the function of this protein–DNA interaction, different in vivo systems have been developed. Chromatin immunoprecipitation experiments using three different cell lines latently infected with KSHV demonstrated that LANA binds preferentially and directly to the terminal repeats (TRs) but not to other regions of the viral chromosome in vivo. In contrast, in vitro LANA–DNA binding was much less specific. To identify autonomously replicating sequences within the KSHV genome, BCBL-1 cells were transfected with cosmids representing the entire genome. Cosmid Z2, consisting of the right end of the unique region and TRs, persisted as an episome in short-term assays. Long term, stable episome replication was observed with constructs derived from Z2 containing TRs only. LANA expression constructs containing a variable number of TRs replicated stably as episomes in uninfected cells. A 424 bp subfragment of the 801 bp TR could mediate episome replication. These studies show that LANA is a trans-acting protein that binds preferentially to TRs in vivo and these two elements are sufficient for episome replication. These results also suggest that the LANA expression plasmids reported here could be utilized as episomal vectors in a manner similar to Epstein–Barr virus-based vectors.

Present address: Veterinary Medical Research Institute, Hungarian Academy of Sciences, Budapest, Hungary.

This article has been cited by other articles:

				G. Fejer, A. Koroknai, F. Banati, I. Gyory, D. Salamon, H. Wolf, H. H. Niller, and J. Minarovits Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus J. Gen. Virol., June 1, 2008; 89(6): 1364 - 1370. [Abstract] [Full Text] [PDF]

				B. Gerle, A. Koroknai, G. Fejer, A. Bakos, F. Banati, K. Szenthe, H. Wolf, H. H. Niller, J. Minarovits, and D. Salamon Acetylated Histone H3 and H4 Mark the Upregulated LMP2A Promoter of Epstein-Barr Virus in Lymphoid Cells J. Virol., December 1, 2007; 81(23): 13242 - 13247. [Abstract] [Full Text] [PDF]

				J. Liu, H. J. Martin, G. Liao, and S. D. Hayward The Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Stabilizes and Activates c-Myc J. Virol., October 1, 2007; 81(19): 10451 - 10459. [Abstract] [Full Text] [PDF]

				J. Liu, H. Martin, M. Shamay, C. Woodard, Q.-Q. Tang, and S. D. Hayward Kaposi's Sarcoma-Associated Herpesvirus LANA Protein Downregulates Nuclear Glycogen Synthase Kinase 3 Activity and Consequently Blocks Differentiation J. Virol., May 1, 2007; 81(9): 4722 - 4731. [Abstract] [Full Text] [PDF]

				S. C. Verma, T. Choudhuri, and E. S. Robertson The Minimal Replicator Element of the Kaposi's Sarcoma-Associated Herpesvirus Terminal Repeat Supports Replication in a Semiconservative and Cell-Cycle-Dependent Manner J. Virol., April 1, 2007; 81(7): 3402 - 3413. [Abstract] [Full Text] [PDF]

				B. Alberter and A. Ensser Histone Modification Pattern of the T-Cellular Herpesvirus Saimiri Genome in Latency J. Virol., March 1, 2007; 81(5): 2524 - 2530. [Abstract] [Full Text] [PDF]

				S. Roessler, I. Gyory, S. Imhof, M. Spivakov, R. R. Williams, M. Busslinger, A. G. Fisher, and R. Grosschedl Distinct Promoters Mediate the Regulation of Ebf1 Gene Expression by Interleukin-7 and Pax5 Mol. Cell. Biol., January 15, 2007; 27(2): 579 - 594. [Abstract] [Full Text] [PDF]

				S. Corte-Real, C. Collins, F. A. da Silva, J. P. Simas, C. F. Barbas III, Y. Chang, P. Moore, and J. Goncalves Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells Blood, December 1, 2005; 106(12): 3797 - 3802. [Abstract] [Full Text] [PDF]

				L.-Y. Wong and A. C. Wilson Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces a Strong Bend on Binding to Terminal Repeat DNA J. Virol., November 1, 2005; 79(21): 13829 - 13836. [Abstract] [Full Text] [PDF]

				M. Fujimuro, J. Liu, J. Zhu, H. Yokosawa, and S. D. Hayward Regulation of the Interaction between Glycogen Synthase Kinase 3 and the Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen J. Virol., August 15, 2005; 79(16): 10429 - 10441. [Abstract] [Full Text] [PDF]

				W. Stedman, Z. Deng, F. Lu, and P. M. Lieberman ORC, MCM, and Histone Hyperacetylation at the Kaposi's Sarcoma-Associated Herpesvirus Latent Replication Origin J. Virol., November 15, 2004; 78(22): 12566 - 12575. [Abstract] [Full Text] [PDF]

				F.-C. Ye, F.-C. Zhou, S. M. Yoo, J.-P. Xie, P. J. Browning, and S.-J. Gao Disruption of Kaposi's Sarcoma-Associated Herpesvirus Latent Nuclear Antigen Leads to Abortive Episome Persistence J. Virol., October 15, 2004; 78(20): 11121 - 11129. [Abstract] [Full Text] [PDF]

				L. Gillet, F. Minner, B. Detry, F. Farnir, L. Willems, M. Lambot, E. Thiry, P.-P. Pastoret, F. Schynts, and A. Vanderplasschen Investigation of the Susceptibility of Human Cell Lines to Bovine Herpesvirus 4 Infection: Demonstration that Human Cells Can Support a Nonpermissive Persistent Infection Which Protects Them against Tumor Necrosis Factor Alpha-Induced Apoptosis J. Virol., March 1, 2004; 78(5): 2336 - 2347. [Abstract] [Full Text] [PDF]

				A. J. Barbera, M. E. Ballestas, and K. M. Kaye The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 N Terminus Is Essential for Chromosome Association, DNA Replication, and Episome Persistence J. Virol., January 1, 2004; 78(1): 294 - 301. [Abstract] [Full Text] [PDF]

				R. E. White, M. A. Calderwood, and A. Whitehouse Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence J. Gen. Virol., December 1, 2003; 84(12): 3393 - 3403. [Abstract] [Full Text] [PDF]